Mexican research proposes alternative therapy against lung cancer

January 7, 2014

Research from the National Institute of Respiratory Diseases (INER) reveals that besides smoking, there are other factors associated with the development of lung cancer such as the smoke from burning lumber and coal, as well as pollutant particles.

"It has been considered that the upturn in cases of is possibly related to these particles", explains Patricia Gorocica from the INER, who, alongside her research team, has been working in an to boost the immune system of patients with this disease.

The specialist adds that for several years, it has been known that the immune system has all the mechanisms to monitor and destroy tumor cells as they develop, but sometimes these mechanisms are not effective for reasons associated with the tumor or changes in the patient's health.

Based on this principle, research at INER is focused on regulating the immune system against tumors. The tumors that can be more easily eliminated are the ones that express specific antigens.

Patricia Gorocica, chief of the Department of Biochemical Research at INER, says that with current technology, it is possible to manipulate the against tumors.

"We are developing at the lab a system of cell activation from the patient's own blood that can eliminate its tumors".

This is preliminary research, but it could be methodized as an alternative therapy for the patients with lung cancer. The labor is being done with the support of the institutes of Biotechnology and Chemistry of the Autonomous National University of Mexico (UNAM), hoping that others will add to the cause, since this research requires a multi-disciplinary team for succeeding.

Gorocica adds that manipulating the immune system could be a new complementary therapy to chemo- and radiotherapies usually used for treating lung cancer.

The at INER is mainly focused in patients with , a type of cancer that has the most alterations in its . It usually affects people of various ages, especially in people over 40, but has been known to affect the 20-something population.

Explore further: Clinical trial examines use of human immune system to fight aggressive lung cancer

Related Stories

Researchers discover how cancer 'invisibility cloak' works

October 28, 2013

Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds to killer T cells, ...

Anti-tumor activity of immune cells can be restored

December 10, 2013

The Leuven-based VIB researchers have revealed a mechanism that explains why the anti-tumor activity of specific immune cells called macrophages is suppressed during tumor growth. They have also demonstrated that blocking ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.